SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 160 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,460,000 | +227.4% | 86,896 | +213.5% | 0.16% | +327.0% |
| Q1 2018 | $446,000 | -57.6% | 27,720 | -62.9% | 0.04% | -63.0% |
| Q3 2017 | $1,052,000 | +104.7% | 74,774 | -35.5% | 0.10% | +58.7% |
| Q4 2016 | $514,000 | -64.2% | 115,953 | -46.9% | 0.06% | -65.2% |
| Q2 2016 | $1,436,000 | +318.7% | 218,519 | +284.4% | 0.18% | +86.6% |
| Q4 2015 | $343,000 | – | 56,842 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
| ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
| NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
| Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
| Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
| Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
| J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
| J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
| Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |